After-hours movers: Cano Health sinks on 'going concern' doubt, Maxeon falls on results

This post was originally published on this site

Cano Health Inc (NYSE:CANO50% LOWER; reported Q2 EPS of ($0.51), $0.40 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $766.7 million versus the consensus estimate of $829 million. In addition, management has concluded that there is substantial doubt about the Company’s ability to continue as a “going concern” within one year.

Pagaya (NASDAQ:PGY25% HIGHER; reported Q2 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $185.69 million versus the consensus estimate of $188.94 million. Pagaya Technologies Ltd. sees Q3 2023 revenue of $190-200 million, versus the consensus of $207.9 million. Pagaya Technologies Ltd. sees FY2023 revenue of $775-825 million, versus the consensus of $803.1 million.

Maxeon Solar Technologies Ltd (NASDAQ:MAXN19% LOWER; reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $348.4 million versus the consensus estimate of $378.23 million. Maxeon sees Q3 revenue of $280-$320 million, versus the consensus of $395.3 million. Maxeion sees FY revenue of $1.25-$1.35 billion, versus the consensus of $1.51 billion.

Arlo Technologies , Inc. (NYSE:ARLO) 5% LOWER; reported Q2 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $115.1 million versus the consensus estimate of $110.18 million.

MercadoLibre , Inc. (NASDAQ:MELI) 3% LOWER; announced today the appointment of MartiĀ­n de los Santos as its new CFO. The current CFO, Pedro Arnt, will leave his position to pursue new opportunities outside the company.